NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 147 filers reported holding NATERA INC in Q3 2018. The put-call ratio across all filers is 0.10 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,863 | -99.9% | 33,558 | +47.2% | 0.00% | -66.7% |
Q1 2021 | $2,315,000 | -4.7% | 22,800 | -6.6% | 0.01% | 0.0% |
Q4 2020 | $2,428,000 | +31.8% | 24,400 | -4.3% | 0.01% | +12.5% |
Q3 2020 | $1,842,000 | +33.9% | 25,500 | -7.6% | 0.01% | +33.3% |
Q2 2020 | $1,376,000 | +45.5% | 27,600 | -12.9% | 0.01% | +20.0% |
Q1 2020 | $946,000 | -9.1% | 31,700 | +2.6% | 0.01% | +25.0% |
Q4 2019 | $1,041,000 | -47.1% | 30,900 | -48.5% | 0.00% | 0.0% |
Q3 2019 | $1,968,000 | +257.2% | 60,000 | +200.0% | 0.00% | +100.0% |
Q2 2019 | $551,000 | -20.1% | 20,000 | -40.3% | 0.00% | -33.3% |
Q1 2019 | $690,000 | +47.8% | 33,500 | 0.0% | 0.00% | +50.0% |
Q4 2018 | $467,000 | -41.7% | 33,500 | 0.0% | 0.00% | -50.0% |
Q3 2018 | $801,000 | -20.8% | 33,500 | -37.7% | 0.00% | 0.0% |
Q2 2018 | $1,012,000 | +47.7% | 53,800 | -27.3% | 0.00% | +33.3% |
Q1 2018 | $685,000 | +21.5% | 74,000 | +17.8% | 0.00% | +50.0% |
Q4 2017 | $564,000 | -19.8% | 62,800 | +15.0% | 0.00% | -33.3% |
Q3 2017 | $703,000 | +6.5% | 54,600 | -10.2% | 0.00% | 0.0% |
Q2 2017 | $660,000 | +29.7% | 60,800 | +5.9% | 0.00% | +50.0% |
Q1 2017 | $509,000 | -24.3% | 57,400 | 0.0% | 0.00% | -33.3% |
Q4 2016 | $672,000 | +18.1% | 57,400 | +11.9% | 0.00% | 0.0% |
Q3 2016 | $569,000 | +84.7% | 51,304 | +100.4% | 0.00% | +200.0% |
Q2 2016 | $308,000 | +40.6% | 25,600 | +10.8% | 0.00% | 0.0% |
Q1 2016 | $219,000 | -12.0% | 23,100 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $249,000 | +611.4% | 23,100 | +600.0% | 0.00% | – |
Q3 2015 | $35,000 | – | 3,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |